We want to overcome the major pain points in the clinical trial process, starting with a promise of a 30% increase in productivity in Protocol Design. Espero can eliminate the need for manual workflows, such as those relying on word documents, SharePoint, and email for collaboration; reducing the average time to draft and finalize a protocol from 3-6 months to a fraction of that time. This can help study sponsors overcome compliance challenges and focus on scientific discovery. The FDA reports that 23% of findings are related to protocol compliance and 28% related to documentation, while the EMA reports that 45% of findings are related to documentation. By automating these processes, Espero can help reduce the number of findings and allow clinical teams to focus on the important work of getting therapies to patients.
If you’ve ever lost sleep over delayed study enrollment, consider 1nHealth your new weighted blanket. 1nHealth fills studies through a simple philosophy: Don’t waste the power of…
Leveraging over 30 years of experience working with large biopharma, emerging biotech, CROs, and healthcare companies, the strategic advisors, executives, and subject matter…
Block Clinical is intently focused on streamlining the myriad of logistics involved in traditional, virtual, and hybrid clinical trials. From globally integrated patient…